First Fiduciary Investment Counsel, Inc. Amgen Inc Transaction History

First Fiduciary Investment Counsel, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $200,464 - $265,870	-1,100 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $208,131 - $267,520	1,100 New	1,100 $265,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of First Fiduciary Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on First Fiduciary Investment Counsel, Inc. with notifications on news.